{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:14:43Z","timestamp":1793330083096,"version":"4.5.0"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200838"],"award-info":[{"award-number":["82200838"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370745"],"award-info":[{"award-number":["82370745"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002865","name":"Chongqing Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023QNXM007"],"award-info":[{"award-number":["2023QNXM007"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002865","name":"Chongqing Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["CSTB2023NSCQ-ZDJ0010"],"award-info":[{"award-number":["CSTB2023NSCQ-ZDJ0010"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002865","name":"Chongqing Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2022YSZX-JCX0007CSTB"],"award-info":[{"award-number":["2022YSZX-JCX0007CSTB"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02113-2","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T08:17:12Z","timestamp":1740644232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Metabolic reprogramming of peritoneal mesothelial cells in peritoneal dialysis\u2013associated fibrosis: therapeutic targets and strategies"],"prefix":"10.1186","volume":"23","author":[{"given":"Fang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"2113_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBDCKD Collaboration","year":"2020","unstructured":"Collaboration GBDCKD. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2020;395:709\u201333.","journal-title":"Lancet"},{"key":"2113_CR2","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975\u201382.","journal-title":"Lancet"},{"key":"2113_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/j.ajkd.2020.05.032","volume":"77","author":"Y Cho","year":"2021","unstructured":"Cho Y, Bello AK, Levin A, Lunney M, Osman MA, Ye F, et al. Peritoneal Dialysis use and practice patterns: an International Survey Study. Am J Kidney Dis. 2021;77:315\u201325.","journal-title":"Am J Kidney Dis"},{"key":"2113_CR4","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41581-022-00623-7","volume":"18","author":"AK Bello","year":"2022","unstructured":"Bello AK, Okpechi IG, Osman MA, Cho Y, Cullis B, Htay H, et al. Epidemiology of peritoneal dialysis outcomes. Nat Rev Nephrol. 2022;18:779\u201393.","journal-title":"Nat Rev Nephrol"},{"key":"2113_CR5","doi-asserted-by":"publisher","first-page":"1507265","DOI":"10.3389\/fimmu.2024.1507265","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhang Y, Ma M, Zhuang X, Lu Y, Miao L, et al. Mechanisms underlying the involvement of peritoneal macrophages in the pathogenesis and novel therapeutic strategies for dialysis-induced peritoneal fibrosis. Front Immunol. 2024;15:1507265.","journal-title":"Front Immunol"},{"key":"2113_CR6","doi-asserted-by":"crossref","unstructured":"Ito Y, Sun T, Tawada M, Kinashi H, Yamaguchi M, Katsuno T et al. Pathophysiological mechanisms of peritoneal fibrosis and peritoneal membrane dysfunction in peritoneal Dialysis. Int J Mol Sci. 2024; 25.","DOI":"10.3390\/ijms25168607"},{"key":"2113_CR7","doi-asserted-by":"crossref","unstructured":"Masola V, Bonomini M, Borrelli S, Di Liberato L, Vecchi L, Onisto M et al. Fibrosis of Peritoneal Membrane as target of New therapies in Peritoneal Dialysis. Int J Mol Sci. 2022; 23.","DOI":"10.3390\/ijms23094831"},{"key":"2113_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1440-1797.2010.01390.x","volume":"16","author":"MD Jose","year":"2011","unstructured":"Jose MD, Johnson DW, Mudge DW, Tranaeus A, Voss D, Walker R, et al. Peritoneal dialysis practice in Australia and New Zealand: a call to action. Nephrol (Carlton). 2011;16:19\u201329.","journal-title":"Nephrol (Carlton)"},{"key":"2113_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/0886022X.2018.1496933","volume":"40","author":"C Wu","year":"2018","unstructured":"Wu C, Chen X, Ying Wang A, Chen J, Gao H, Li G, et al. Peritoneal dialysis in Sichuan Province of China - report from the Chinese National Renal Data System. Ren Fail. 2018;40:577\u201382.","journal-title":"Ren Fail"},{"key":"2113_CR10","doi-asserted-by":"publisher","first-page":"1220450","DOI":"10.3389\/fphys.2023.1220450","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Liu Y, Liu J. A review of research progress on mechanisms of peritoneal fibrosis related to peritoneal dialysis. Front Physiol. 2023;14:1220450.","journal-title":"Front Physiol"},{"key":"2113_CR11","doi-asserted-by":"crossref","unstructured":"Suryantoro SD, Thaha M, Sutanto H, Firdausa S. Current insights into Cellular determinants of Peritoneal Fibrosis in Peritoneal Dialysis: a narrative review. J Clin Med. 2023; 12.","DOI":"10.3390\/jcm12134401"},{"key":"2113_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12967-024-05037-6","volume":"22","author":"Q Song","year":"2024","unstructured":"Song Q, Wang P, Wang H, Pan M, Li X, Yao Z, et al. Integrative analysis of chromatin accessibility and transcriptome landscapes in the induction of peritoneal fibrosis by high glucose. J Transl Med. 2024;22:243.","journal-title":"J Transl Med"},{"key":"2113_CR13","doi-asserted-by":"publisher","first-page":"115246","DOI":"10.1016\/j.biopha.2023.115246","volume":"165","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhang HL, Jia L. High glucose dialysate-induced peritoneal fibrosis: pathophysiology, underlying mechanisms and potential therapeutic strategies. Biomed Pharmacother. 2023;165:115246.","journal-title":"Biomed Pharmacother"},{"key":"2113_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/08968608231196033","volume":"44","author":"RT Krediet","year":"2024","unstructured":"Krediet RT, Parikova A. Glucose-induced pseudohypoxia and advanced glycosylation end products explain peritoneal damage in long-term peritoneal dialysis. Perit Dial Int. 2024;44:6\u201315.","journal-title":"Perit Dial Int"},{"key":"2113_CR15","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1038\/s41598-022-08123-1","volume":"12","author":"S Gensberger-Reigl","year":"2022","unstructured":"Gensberger-Reigl S, Weigel I, Stutzer J, Auditore A, Nikolaus T, Pischetsrieder M. Degradation and de novo formation of nine major glucose degradation products during storage of peritoneal dialysis fluids. Sci Rep. 2022;12:4268.","journal-title":"Sci Rep"},{"key":"2113_CR16","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1053\/j.ajkd.2012.05.018","volume":"60","author":"SL Lui","year":"2012","unstructured":"Lui SL, Yung S, Yim A, Wong KM, Tong KL, Wong KS, et al. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial. Am J Kidney Dis. 2012;60:966\u201375.","journal-title":"Am J Kidney Dis"},{"key":"2113_CR17","doi-asserted-by":"crossref","unstructured":"Balzer MS, Rong S, Nordlohne J, Zemtsovski JD, Schmidt S, Stapel B et al. SGLT2 inhibition by Intraperitoneal Dapagliflozin mitigates peritoneal fibrosis and Ultrafiltration failure in a mouse model of chronic peritoneal exposure to High-Glucose Dialysate. Biomolecules. 2020; 10.","DOI":"10.1101\/2020.11.04.366724"},{"key":"2113_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.semcdb.2018.09.007","volume":"92","author":"AW Kastelein","year":"2019","unstructured":"Kastelein AW, Vos LMC, de Jong KH, van Baal J, Nieuwland R, van Noorden CJF, et al. Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature. Semin Cell Dev Biol. 2019;92:27\u201336.","journal-title":"Semin Cell Dev Biol"},{"key":"2113_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/path.4942","volume":"243","author":"A Capobianco","year":"2017","unstructured":"Capobianco A, Cottone L, Monno A, Manfredi AA, Rovere-Querini P. The peritoneum: healing, immunity, and diseases. J Pathol. 2017;243:137\u201347.","journal-title":"J Pathol"},{"key":"2113_CR20","doi-asserted-by":"publisher","first-page":"1387292","DOI":"10.3389\/fimmu.2024.1387292","volume":"15","author":"H Su","year":"2024","unstructured":"Su H, Zou R, Su J, Chen X, Yang H, An N, et al. Sterile inflammation of peritoneal membrane caused by peritoneal dialysis: focus on the communication between immune cells and peritoneal stroma. Front Immunol. 2024;15:1387292.","journal-title":"Front Immunol"},{"key":"2113_CR21","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1002\/ctm2.321","volume":"11","author":"J Zhang","year":"2021","unstructured":"Zhang J, Chen Y, Chen T, Miao B, Tang Z, Hu X, et al. Single-cell transcriptomics provides new insights into the role of fibroblasts during peritoneal fibrosis. Clin Transl Med. 2021;11:e321.","journal-title":"Clin Transl Med"},{"key":"2113_CR22","doi-asserted-by":"publisher","first-page":"885802","DOI":"10.3389\/fphys.2022.885802","volume":"13","author":"RT Krediet","year":"2022","unstructured":"Krediet RT. Aging of the peritoneal Dialysis membrane. Front Physiol. 2022;13:885802.","journal-title":"Front Physiol"},{"key":"2113_CR23","doi-asserted-by":"crossref","unstructured":"Ramil-Gomez O, Lopez-Pardo M, Fernandez-Rodriguez JA, Rodriguez-Carmona A, Perez-Lopez T, Vaamonde-Garcia C et al. Involvement of mitochondrial dysfunction in the inflammatory response in human mesothelial cells from peritoneal Dialysis Effluent. Antioxidants (Basel). 2022; 11.","DOI":"10.3390\/antiox11112184"},{"key":"2113_CR24","doi-asserted-by":"crossref","unstructured":"Ramil-Gomez O, Rodriguez-Carmona A, Fernandez-Rodriguez JA, Perez-Fontan M, Ferreiro-Hermida T, Lopez-Pardo M et al. Mitochondrial dysfunction plays a relevant role in pathophysiology of peritoneal membrane damage Induced by Peritoneal Dialysis. Antioxid (Basel). 2021; 10.","DOI":"10.3390\/antiox10030447"},{"key":"2113_CR25","doi-asserted-by":"publisher","first-page":"1322493","DOI":"10.3389\/fphys.2024.1322493","volume":"15","author":"RT Krediet","year":"2024","unstructured":"Krediet RT. Physiology of peritoneal dialysis; pathophysiology in long-term patients. Front Physiol. 2024;15:1322493.","journal-title":"Front Physiol"},{"key":"2113_CR26","doi-asserted-by":"publisher","first-page":"890881","DOI":"10.3389\/fphar.2022.890881","volume":"13","author":"S Xie","year":"2022","unstructured":"Xie S, Xu F, Lu Y, Zhang Y, Li X, Yu M, et al. Elabela attenuates the TGF-beta1-Induced epithelial-mesenchymal transition of peritoneal mesothelial cells in patients receiving peritoneal Dialysis. Front Pharmacol. 2022;13:890881.","journal-title":"Front Pharmacol"},{"key":"2113_CR27","doi-asserted-by":"crossref","unstructured":"Bonomini M, Masola V, Procino G, Zammit V, Divino-Filho JC, Arduini A et al. How to Improve the Biocompatibility of Peritoneal Dialysis Solutions (without Jeopardizing the Patient\u2019s Health). Int J Mol Sci. 2021; 22.","DOI":"10.3390\/ijms22157955"},{"key":"2113_CR28","doi-asserted-by":"publisher","first-page":"111383","DOI":"10.1016\/j.isci.2024.111383","volume":"27","author":"X Diao","year":"2024","unstructured":"Diao X, Zhan C, Ye H, Wu H, Yi C, Lin J, et al. Single-cell transcriptomic reveals the peritoneal microenvironmental change in long-term peritoneal dialysis patients with ultrafiltration failure. iScience. 2024;27:111383.","journal-title":"iScience"},{"key":"2113_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fphys.2019.00105","volume":"10","author":"Z Yu","year":"2019","unstructured":"Yu Z, Lambie M, Chess J, Williams A, Do JY, Topley N, et al. Peritoneal protein clearance is a function of local inflammation and membrane area whereas systemic inflammation and Comorbidity Predict Survival of Incident Peritoneal Dialysis patients. Front Physiol. 2019;10:105.","journal-title":"Front Physiol"},{"key":"2113_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/0896860820903655","volume":"41","author":"S Law","year":"2021","unstructured":"Law S, Davenport A. The effect of glucose absorption from peritoneal dialysates on changes in lipid profiles in prevalent peritoneal dialysis patients. Perit Dial Int. 2021;41:115\u20137.","journal-title":"Perit Dial Int"},{"key":"2113_CR31","doi-asserted-by":"crossref","unstructured":"DelNero P, Hopkins BD, Cantley LC, Fischbach C. Cancer metabolism gets physical. Sci Transl Med. 2018; 10.","DOI":"10.1126\/scitranslmed.aaq1011"},{"key":"2113_CR32","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Martinez-Reyes","year":"2021","unstructured":"Martinez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21:669\u201380.","journal-title":"Nat Rev Cancer"},{"key":"2113_CR33","doi-asserted-by":"publisher","first-page":"165965","DOI":"10.1016\/j.bbadis.2020.165965","volume":"1867","author":"AM Urbano","year":"2021","unstructured":"Urbano AM. Otto Warburg: the journey towards the seminal discovery of tumor cell bioenergetic reprogramming. Biochim Biophys Acta Mol Basis Dis. 2021;1867:165965.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2113_CR34","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1007\/s00018-021-03892-w","volume":"78","author":"Z Li","year":"2021","unstructured":"Li Z, Lu S, Li X. The role of metabolic reprogramming in tubular epithelial cells during the progression of acute kidney injury. Cell Mol Life Sci. 2021;78:5731\u201341.","journal-title":"Cell Mol Life Sci"},{"key":"2113_CR35","doi-asserted-by":"publisher","first-page":"155194","DOI":"10.1016\/j.metabol.2022.155194","volume":"131","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Hu J, Chen Z, Feng J, Yang X, Liang W, et al. Transition of acute kidney injury to chronic kidney disease: role of metabolic reprogramming. Metabolism. 2022;131:155194.","journal-title":"Metabolism"},{"key":"2113_CR36","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/cac2.12374","volume":"42","author":"T Ge","year":"2022","unstructured":"Ge T, Gu X, Jia R, Ge S, Chai P, Zhuang A, et al. Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities. Cancer Commun (Lond). 2022;42:1049\u201382.","journal-title":"Cancer Commun (Lond)"},{"key":"2113_CR37","doi-asserted-by":"publisher","first-page":"117826","DOI":"10.1016\/j.cca.2024.117826","volume":"555","author":"T Yang","year":"2024","unstructured":"Yang T, Wei B, Liu J, Si X, Wang L, Jiang C. A landscape of metabolic variation among clinical outcomes of peritoneal dialysis in end-stage renal disease. Clin Chim Acta. 2024;555:117826.","journal-title":"Clin Chim Acta"},{"key":"2113_CR38","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/1535370220919364","volume":"245","author":"J Liu","year":"2020","unstructured":"Liu J, Feng Y, Sun C, Zhu W, Zhang QY, Jin B, et al. Valsartan ameliorates high glucose-induced peritoneal fi brosis by blocking mTORC1 signaling. Exp Biol Med (Maywood). 2020;245:983\u201393.","journal-title":"Exp Biol Med (Maywood)"},{"key":"2113_CR39","doi-asserted-by":"publisher","first-page":"2149411","DOI":"10.1080\/0886022X.2022.2149411","volume":"45","author":"Q Wang","year":"2023","unstructured":"Wang Q, Sun J, Wang R, Sun J. Inhibition of EZH2 mitigates peritoneal fibrosis and lipid precipitation in peritoneal mesothelial cells mediated by klotho. Ren Fail. 2023;45:2149411.","journal-title":"Ren Fail"},{"key":"2113_CR40","doi-asserted-by":"publisher","first-page":"F273","DOI":"10.1152\/ajprenal.00149.2020","volume":"320","author":"J Liu","year":"2021","unstructured":"Liu J, Feng Y, Li N, Shao QY, Zhang QY, Sun C, et al. Activation of the RAS contributes to peritoneal fibrosis via dysregulation of low-density lipoprotein receptor. Am J Physiol Ren Physiol. 2021;320:F273\u201384.","journal-title":"Am J Physiol Ren Physiol"},{"key":"2113_CR41","doi-asserted-by":"publisher","first-page":"F167","DOI":"10.1152\/ajprenal.00052.2017","volume":"314","author":"T Kariya","year":"2018","unstructured":"Kariya T, Nishimura H, Mizuno M, Suzuki Y, Matsukawa Y, Sakata F, et al. TGF-beta1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis. Am J Physiol Ren Physiol. 2018;314:F167\u201380.","journal-title":"Am J Physiol Ren Physiol"},{"key":"2113_CR42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11684-017-0571-2","volume":"11","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Jiang N, Ni Z. Strategies for preventing peritoneal fibrosis in peritoneal dialysis patients: new insights based on peritoneal inflammation and angiogenesis. Front Med. 2017;11:349\u201358.","journal-title":"Front Med"},{"key":"2113_CR43","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2215\/CJN.15371121","volume":"17","author":"RT Krediet","year":"2022","unstructured":"Krediet RT, Parikova A. Relative contributions of Pseudohypoxia and inflammation to peritoneal alterations with long-term peritoneal Dialysis patients. Clin J Am Soc Nephrol. 2022;17:1259\u201366.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2113_CR44","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1681\/ASN.2021010080","volume":"32","author":"RT Krediet","year":"2021","unstructured":"Krediet RT. Acquired decline in Ultrafiltration in Peritoneal Dialysis: the role of glucose. J Am Soc Nephrol. 2021;32:2408\u201315.","journal-title":"J Am Soc Nephrol"},{"key":"2113_CR45","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.7150\/thno.84921","volume":"13","author":"W Su","year":"2023","unstructured":"Su W, Hu Z, Zhong X, Cong A, Zhang Y, Zhou Z, et al. Restoration of CPT1A-mediated fatty acid oxidation in mesothelial cells protects against peritoneal fibrosis. Theranostics. 2023;13:4482\u201396.","journal-title":"Theranostics"},{"key":"2113_CR46","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.fertnstert.2016.09.005","volume":"106","author":"SE Mutsaers","year":"2016","unstructured":"Mutsaers SE, Prele CM, Pengelly S, Herrick SE. Mesothelial cells and peritoneal homeostasis. Fertil Steril. 2016;106:1018\u201324.","journal-title":"Fertil Steril"},{"key":"2113_CR47","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s42255-021-00483-8","volume":"3","author":"CD Wiley","year":"2021","unstructured":"Wiley CD, Campisi J. The metabolic roots of senescence: mechanisms and opportunities for intervention. Nat Metab. 2021;3:1290\u2013301.","journal-title":"Nat Metab"},{"key":"2113_CR48","doi-asserted-by":"crossref","unstructured":"Si M, Wang Q, Li Y, Lin H, Luo D, Zhao W et al. Inhibition of hyperglycolysis in mesothelial cells prevents peritoneal fibrosis. Sci Transl Med. 2019; 11.","DOI":"10.1126\/scitranslmed.aav5341"},{"key":"2113_CR49","doi-asserted-by":"publisher","first-page":"106336","DOI":"10.1016\/j.isci.2023.106336","volume":"26","author":"W Hu","year":"2023","unstructured":"Hu W, Li G, Dong W, He P, Liu W, Wu Y, et al. Single-cell sequencing reveals peritoneal environment and insights into fibrosis in CAPD patients. iScience. 2023;26:106336.","journal-title":"iScience"},{"key":"2113_CR50","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.kint.2016.01.025","volume":"89","author":"L Wang","year":"2016","unstructured":"Wang L, Balzer MS, Rong S, Menne J, von Vietinghoff S, Dong L, et al. Protein kinase C alpha inhibition prevents peritoneal damage in a mouse model of chronic peritoneal exposure to high-glucose dialysate. Kidney Int. 2016;89:1253\u201367.","journal-title":"Kidney Int"},{"key":"2113_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/HP.S202775","volume":"7","author":"J Song","year":"2019","unstructured":"Song J, Yang X, Yan LJ. Role of pseudohypoxia in the pathogenesis of type 2 diabetes. Hypoxia (Auckl). 2019;7:33\u201340.","journal-title":"Hypoxia (Auckl)"},{"key":"2113_CR52","doi-asserted-by":"publisher","first-page":"1152611","DOI":"10.3389\/fphar.2023.1152611","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang J, Lv X, AS AN-W, Tian SS, Wang JM, Liu HY, et al. Canagliflozin alleviates high glucose-induced peritoneal fibrosis via HIF-1alpha inhibition. Front Pharmacol. 2023;14:1152611.","journal-title":"Front Pharmacol"},{"key":"2113_CR53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1113\/JP280572","volume":"599","author":"SJ Kierans","year":"2021","unstructured":"Kierans SJ, Taylor CT. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology. J Physiol. 2021;599:23\u201337.","journal-title":"J Physiol"},{"key":"2113_CR54","doi-asserted-by":"publisher","first-page":"109778","DOI":"10.1016\/j.cellsig.2020.109778","volume":"75","author":"MS Balzer","year":"2020","unstructured":"Balzer MS. Molecular pathways in peritoneal fibrosis. Cell Signal. 2020;75:109778.","journal-title":"Cell Signal"},{"key":"2113_CR55","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41580-021-00415-0","volume":"23","author":"I Vercellino","year":"2022","unstructured":"Vercellino I, Sazanov LA. The assembly, regulation and function of the mitochondrial respiratory chain. Nat Rev Mol Cell Biol. 2022;23:141\u201361.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2113_CR56","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-pathmechdis-012419-032711","volume":"15","author":"DC Chan","year":"2020","unstructured":"Chan DC. Mitochondrial dynamics and its involvement in Disease. Annu Rev Pathol. 2020;15:235\u201359.","journal-title":"Annu Rev Pathol"},{"key":"2113_CR57","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41586-019-1738-6","volume":"575","author":"T MacVicar","year":"2019","unstructured":"MacVicar T, Ohba Y, Nolte H, Mayer FC, Tatsuta T, Sprenger HG, et al. Lipid signalling drives proteolytic rewiring of mitochondria by YME1L. Nature. 2019;575:361\u20135.","journal-title":"Nature"},{"key":"2113_CR58","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1159\/000139638","volume":"28","author":"JB Chen","year":"2008","unstructured":"Chen JB, Lin TK, Liou CW, Liao SC, Lee LC, Wang PW, et al. Correlation of oxidative stress biomarkers and peritoneal urea clearance with mitochondrial DNA copy number in continuous ambulatory peritoneal dialysis patients. Am J Nephrol. 2008;28:853\u20139.","journal-title":"Am J Nephrol"},{"key":"2113_CR59","doi-asserted-by":"crossref","unstructured":"Oberacker T, Fritz P, Schanz M, Alscher MD, Ketteler M, Schricker S. Enhanced oxidative DNA-Damage in peritoneal Dialysis patients via the TXNIP\/TRX Axis. Antioxid (Basel). 2022; 11.","DOI":"10.3390\/antiox11061124"},{"key":"2113_CR60","doi-asserted-by":"crossref","unstructured":"Hung KY, Liu SY, Yang TC, Liao TL, Kao SH. High-dialysate-glucose-induced oxidative stress and mitochondrial-mediated apoptosis in human peritoneal mesothelial cells. Oxid Med Cell Longev. 2014; 2014: 642793.","DOI":"10.1155\/2014\/642793"},{"issue":"Suppl 3","key":"2113_CR61","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1177\/089686080502503S05","volume":"25","author":"R van Westrhenen","year":"2005","unstructured":"van Westrhenen R, Aten J, Aberra M, Dragt CA, Deira G, Krediet RT. Effects of inhibition of the polyol pathway during chronic peritoneal exposure to a dialysis solution. Perit Dial Int. 2005;25(Suppl 3):S18\u201321.","journal-title":"Perit Dial Int"},{"key":"2113_CR62","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1046\/j.1523-1755.2003.00883.x","volume":"63","author":"TY Wong","year":"2003","unstructured":"Wong TY, Phillips AO, Witowski J, Topley N. Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int. 2003;63:1404\u201316.","journal-title":"Kidney Int"},{"key":"2113_CR63","doi-asserted-by":"publisher","first-page":"e3001678","DOI":"10.1371\/journal.pbio.3001678","volume":"20","author":"H Sano","year":"2022","unstructured":"Sano H, Nakamura A, Yamane M, Niwa H, Nishimura T, Araki K, et al. The polyol pathway is an evolutionarily conserved system for sensing glucose uptake. PLoS Biol. 2022;20:e3001678.","journal-title":"PLoS Biol"},{"key":"2113_CR64","doi-asserted-by":"publisher","first-page":"106326","DOI":"10.1016\/j.phrs.2022.106326","volume":"182","author":"SS Garg","year":"2022","unstructured":"Garg SS, Gupta J. Polyol pathway and redox balance in diabetes. Pharmacol Res. 2022;182:106326.","journal-title":"Pharmacol Res"},{"key":"2113_CR65","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13065-021-00756-z","volume":"15","author":"MM Bacha","year":"2021","unstructured":"Bacha MM, Nadeem H, Zaib S, Sarwar S, Imran A, Rahman SU, et al. Rhodanine-3-acetamide derivatives as aldose and aldehyde reductase inhibitors to treat diabetic complications: synthesis, biological evaluation, molecular docking and simulation studies. BMC Chem. 2021;15:28.","journal-title":"BMC Chem"},{"key":"2113_CR66","first-page":"1473","volume":"11","author":"J Liu","year":"2019","unstructured":"Liu J, Jiang CM, Feng Y, Zhu W, Jin B, Xia YY, et al. Rapamycin inhibits peritoneal fibrosis by modifying lipid homeostasis in the peritoneum. Am J Transl Res. 2019;11:1473\u201385.","journal-title":"Am J Transl Res"},{"key":"2113_CR67","doi-asserted-by":"publisher","first-page":"101193","DOI":"10.1016\/j.plipres.2022.101193","volume":"88","author":"Y Li","year":"2022","unstructured":"Li Y, Huang X, Yang G, Xu K, Yin Y, Brecchia G, et al. CD36 favours fat sensing and transport to govern lipid metabolism. Prog Lipid Res. 2022;88:101193.","journal-title":"Prog Lipid Res"},{"key":"2113_CR68","doi-asserted-by":"crossref","unstructured":"Kawamura S, Matsushita Y, Kurosaki S, Tange M, Fujiwara N, Hayata Y et al. Inhibiting SCAP\/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis. J Clin Invest. 2022; 132.","DOI":"10.1172\/JCI151895"},{"key":"2113_CR69","doi-asserted-by":"crossref","unstructured":"Schlaepfer IR, Joshi M. CPT1A-mediated Fat Oxidation, mechanisms, and therapeutic potential. Endocrinology. 2020; 161.","DOI":"10.1210\/endocr\/bqz046"},{"key":"2113_CR70","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo J, Yang H, Song BL. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21:225\u201345.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2113_CR71","doi-asserted-by":"publisher","first-page":"1414070","DOI":"10.1155\/2017\/1414070","volume":"2017","author":"L Feng","year":"2017","unstructured":"Feng L, Gu C, Li Y, Huang J. High glucose promotes CD36 expression by upregulating peroxisome proliferator-activated receptor gamma levels to exacerbate lipid deposition in renal tubular cells. Biomed Res Int. 2017;2017:1414070.","journal-title":"Biomed Res Int"},{"key":"2113_CR72","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.mito.2018.02.009","volume":"46","author":"MM Adeva-Andany","year":"2019","unstructured":"Adeva-Andany MM, Carneiro-Freire N, Seco-Filgueira M, Fernandez-Fernandez C, Mourino-Bayolo D. Mitochondrial beta-oxidation of saturated fatty acids in humans. Mitochondrion. 2019;46:73\u201390.","journal-title":"Mitochondrion"},{"key":"2113_CR73","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.7150\/thno.50905","volume":"11","author":"M Zhao","year":"2021","unstructured":"Zhao M, Wang Y, Li L, Liu S, Wang C, Yuan Y, et al. Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance. Theranostics. 2021;11:1845\u201363.","journal-title":"Theranostics"},{"key":"2113_CR74","doi-asserted-by":"publisher","first-page":"e66270","DOI":"10.1371\/journal.pone.0066270","volume":"8","author":"Y Fujieda","year":"2013","unstructured":"Fujieda Y, Manno A, Hayashi Y, Rhodes N, Guo L, Arita M, et al. Inflammation and resolution are associated with upregulation of fatty acid beta-oxidation in Zymosan-induced peritonitis. PLoS ONE. 2013;8:e66270.","journal-title":"PLoS ONE"},{"key":"2113_CR75","doi-asserted-by":"publisher","first-page":"113417","DOI":"10.1016\/j.yexcr.2022.113417","volume":"422","author":"Q Liu","year":"2023","unstructured":"Liu Q, Deng C, Xing X, Hu Y, Wang Z, Liang Y. Silencing RIPK1\/mTORC1 signalling attenuated the inflammation and oxidative stress in diabetic cardiomyopathy. Exp Cell Res. 2023;422:113417.","journal-title":"Exp Cell Res"},{"key":"2113_CR76","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1080\/0886022X.2022.2133729","volume":"44","author":"J Liu","year":"2022","unstructured":"Liu J, Jin B, Lu J, Feng Y, Li N, Wan C, et al. Angiotensin II type 2 receptor prevents extracellular matrix accumulation in human peritoneal mesothelial cell by ameliorating lipid disorder via LOX-1 suppression. Ren Fail. 2022;44:1687\u201397.","journal-title":"Ren Fail"},{"key":"2113_CR77","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.cmet.2019.02.011","volume":"29","author":"IY Benador","year":"2019","unstructured":"Benador IY, Veliova M, Liesa M, Shirihai OS. Mitochondria bound to lipid droplets: where mitochondrial dynamics regulate lipid storage and utilization. Cell Metab. 2019;29:827\u201335.","journal-title":"Cell Metab"},{"key":"2113_CR78","doi-asserted-by":"crossref","unstructured":"Cavaliere G, Cimmino F, Trinchese G, Catapano A, Petrella L, D\u2019Angelo M et al. From obesity-Induced Low-Grade inflammation to Lipotoxicity and mitochondrial dysfunction: altered multi-crosstalk between adipose tissue and metabolically active organs. Antioxidants (Basel). 2023; 12.","DOI":"10.3390\/antiox12061172"},{"key":"2113_CR79","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3389\/fphys.2020.00732","volume":"11","author":"M Ge","year":"2020","unstructured":"Ge M, Fontanesi F, Merscher S, Fornoni A. The vicious cycle of renal lipotoxicity and mitochondrial dysfunction. Front Physiol. 2020;11:732.","journal-title":"Front Physiol"},{"key":"2113_CR80","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10565-021-09692-z","volume":"39","author":"XM Ma","year":"2023","unstructured":"Ma XM, Geng K, Law BY, Wang P, Pu YL, Chen Q, et al. Lipotoxicity-induced mtDNA release promotes diabetic cardiomyopathy by activating the cGAS-STING pathway in obesity-related diabetes. Cell Biol Toxicol. 2023;39:277\u201399.","journal-title":"Cell Biol Toxicol"},{"key":"2113_CR81","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s13046-023-02845-4","volume":"42","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Yao Y, Ge T, Ge S, Jia R, Song X, et al. Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity. J Exp Clin Cancer Res. 2023;42:291.","journal-title":"J Exp Clin Cancer Res"},{"key":"2113_CR82","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","volume":"25","author":"P Puchalska","year":"2017","unstructured":"Puchalska P, Crawford PA. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab. 2017;25:262\u201384.","journal-title":"Cell Metab"},{"key":"2113_CR83","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41389-023-00464-4","volume":"12","author":"Y Tang","year":"2023","unstructured":"Tang Y, Li W, Qiu L, Zhang X, Zhang L, Miyagishi M, et al. The p52-ZER6\/G6PD axis alters aerobic glycolysis and promotes tumor progression by activating the pentose phosphate pathway. Oncogenesis. 2023;12:17.","journal-title":"Oncogenesis"},{"key":"2113_CR84","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s42255-023-00863-2","volume":"5","author":"T TeSlaa","year":"2023","unstructured":"TeSlaa T, Ralser M, Fan J, Rabinowitz JD. The pentose phosphate pathway in health and disease. Nat Metab. 2023;5:1275\u201389.","journal-title":"Nat Metab"},{"key":"2113_CR85","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12933-016-0397-2","volume":"15","author":"C Peiro","year":"2016","unstructured":"Peiro C, Romacho T, Azcutia V, Villalobos L, Fernandez E, Bolanos JP, et al. Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway. Cardiovasc Diabetol. 2016;15:82.","journal-title":"Cardiovasc Diabetol"},{"key":"2113_CR86","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s42255-019-0043-x","volume":"1","author":"L Chen","year":"2019","unstructured":"Chen L, Zhang Z, Hoshino A, Zheng HD, Morley M, Arany Z, et al. NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism. Nat Metab. 2019;1:404\u201315.","journal-title":"Nat Metab"},{"key":"2113_CR87","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1177\/08968608211035964","volume":"42","author":"O Iyasere","year":"2022","unstructured":"Iyasere O, Nagar R, Jesus-Silva JA, Pepereke S, MacConaill K, Eid A, et al. The impact of amino acid dialysate on anthropometric measures in adult patients on peritoneal dialysis: a systematic review and meta-analysis. Perit Dial Int. 2022;42:314\u201323.","journal-title":"Perit Dial Int"},{"key":"2113_CR88","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/ndt\/gfg096","volume":"18","author":"TM Chan","year":"2003","unstructured":"Chan TM, Leung JK, Sun Y, Lai KN, Tsang RC, Yung S. Different effects of amino acid-based and glucose-based dialysate from peritoneal dialysis patients on mesothelial cell ultrastructure and function. Nephrol Dial Transpl. 2003;18:1086\u201394.","journal-title":"Nephrol Dial Transpl"},{"key":"2113_CR89","doi-asserted-by":"crossref","unstructured":"Tjiong HL, Zijlstra FJ, Rietveld T, Wattimena JL, Huijmans JG, Swart GR et al. Peritoneal protein losses and cytokine generation in automated peritoneal dialysis with combined amino acids and glucose solutions. Mediators Inflamm. 2007; 2007: 97272.","DOI":"10.1155\/2007\/97272"},{"key":"2113_CR90","doi-asserted-by":"crossref","unstructured":"Herzog R, Bartosova M, Tarantino S, Wagner A, Unterwurzacher M, Sacnun JM et al. Peritoneal Dialysis fluid supplementation with Alanyl-Glutamine attenuates conventional Dialysis fluid-mediated endothelial cell Injury by restoring perturbed cytoprotective responses. Biomolecules. 2020; 10.","DOI":"10.3390\/biom10121678"},{"key":"2113_CR91","doi-asserted-by":"publisher","first-page":"e0165045","DOI":"10.1371\/journal.pone.0165045","volume":"11","author":"K Kratochwill","year":"2016","unstructured":"Kratochwill K, Boehm M, Herzog R, Gruber K, Lichtenauer AM, Kuster L, et al. Addition of Alanyl-glutamine to Dialysis Fluid restores peritoneal Cellular stress responses - A First-In-Man Trial. PLoS ONE. 2016;11:e0165045.","journal-title":"PLoS ONE"},{"key":"2113_CR92","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","volume":"52","author":"HC Yoo","year":"2020","unstructured":"Yoo HC, Yu YC, Sung Y, Han JM. Glutamine reliance in cell metabolism. Exp Mol Med. 2020;52:1496\u2013516.","journal-title":"Exp Mol Med"},{"key":"2113_CR93","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1038\/s42255-023-00935-3","volume":"5","author":"AB Nelson","year":"2023","unstructured":"Nelson AB, Queathem ED, Puchalska P, Crawford PA. Metabolic messengers: ketone bodies. Nat Metab. 2023;5:2062\u201374.","journal-title":"Nat Metab"},{"key":"2113_CR94","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-nutr-111120-111518","volume":"41","author":"P Puchalska","year":"2021","unstructured":"Puchalska P, Crawford PA. Metabolic and Signaling Roles of Ketone Bodies in Health and Disease. Annu Rev Nutr. 2021;41:49\u201377.","journal-title":"Annu Rev Nutr"},{"key":"2113_CR95","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1113\/JP284270","volume":"601","author":"AA Kadir","year":"2023","unstructured":"Kadir AA, Stubbs BJ, Chong CR, Lee H, Cole M, Carr C, et al. On the interdependence of ketone body oxidation, glycogen content, glycolysis and energy metabolism in the heart. J Physiol. 2023;601:1207\u201324.","journal-title":"J Physiol"},{"key":"2113_CR96","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lfs.2016.07.018","volume":"161","author":"Y Debray-Garcia","year":"2016","unstructured":"Debray-Garcia Y, Sanchez EI, Rodriguez-Munoz R, Venegas MA, Velazquez J, Reyes JL. Diabetes and exposure to peritoneal dialysis solutions alter tight junction proteins and glucose transporters of rat peritoneal mesothelial cells. Life Sci. 2016;161:78\u201389.","journal-title":"Life Sci"},{"key":"2113_CR97","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000520894","volume":"47","author":"S Schricker","year":"2022","unstructured":"Schricker S, Oberacker T, Fritz P, Ketteler M, Alscher MD, Schanz M. Peritoneal expression of SGLT-2, GLUT1, and GLUT3 in peritoneal Dialysis patients. Kidney Blood Press Res. 2022;47:125\u201334.","journal-title":"Kidney Blood Press Res"},{"key":"2113_CR98","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1002\/anie.201909518","volume":"58","author":"J Ceballos","year":"2019","unstructured":"Ceballos J, Schwalfenberg M, Karageorgis G, Reckzeh ES, Sievers S, Ostermann C, et al. Synthesis of Indomorphan Pseudo-natural product inhibitors of glucose transporters GLUT-1 and\u2013\u20093. Angew Chem Int Ed Engl. 2019;58:17016\u201325.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2113_CR99","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.biopha.2018.10.106","volume":"109","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Fan J, Zheng C, Yin P, Wu H, Li X, et al. SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2. Biomed Pharmacother. 2019;109:1327\u201338.","journal-title":"Biomed Pharmacother"},{"key":"2113_CR100","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1080\/0886022X.2022.2118066","volume":"44","author":"P Shi","year":"2022","unstructured":"Shi P, Zhan Z, Ye X, Lu Y, Song K, Sheng F, et al. The antioxidative effects of empagliflozin on high glucose\u2013induced epithelial-mesenchymal transition in peritoneal mesothelial cells via the Nrf2\/HO-1 signaling. Ren Fail. 2022;44:1528\u201342.","journal-title":"Ren Fail"},{"key":"2113_CR101","doi-asserted-by":"publisher","first-page":"107374","DOI":"10.1016\/j.intimp.2021.107374","volume":"93","author":"Y Shentu","year":"2021","unstructured":"Shentu Y, Li Y, Xie S, Jiang H, Sun S, Lin R, et al. Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-beta\/Smad signaling. Int Immunopharmacol. 2021;93:107374.","journal-title":"Int Immunopharmacol"},{"key":"2113_CR102","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1177\/08968608211008095","volume":"41","author":"G Martus","year":"2021","unstructured":"Martus G, Bergling K, de Arteaga J, Oberg CM. SGLT2 inhibition does not reduce glucose absorption during experimental peritoneal dialysis. Perit Dial Int. 2021;41:373\u201380.","journal-title":"Perit Dial Int"},{"key":"2113_CR103","doi-asserted-by":"crossref","unstructured":"Yaribeygi H, Maleki M, Reiner Z, Jamialahmadi T, Sahebkar A. Mechanistic view on the effects of SGLT2 inhibitors on lipid metabolism in Diabetic Milieu. J Clin Med. 2022; 11.","DOI":"10.3390\/jcm11216544"},{"key":"2113_CR104","doi-asserted-by":"crossref","unstructured":"Szekeres Z, Toth K, Szabados E. The Effects of SGLT2 Inhibitors on Lipid Metabolism. Metabolites. 2021; 11.","DOI":"10.3390\/metabo11020087"},{"key":"2113_CR105","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/jcb.30327","volume":"123","author":"H Yaribeygi","year":"2022","unstructured":"Yaribeygi H, Maleki M, Butler AE, Jamialahmadi T, Sahebkar A. New insights into cellular links between sodium-glucose cotransporter-2 inhibitors and ketogenesis. J Cell Biochem. 2022;123:1879\u201390.","journal-title":"J Cell Biochem"},{"key":"2113_CR106","first-page":"53","volume":"22","author":"H Yaribeygi","year":"2023","unstructured":"Yaribeygi H, Maleki M, Butler AE, Jamialahmadi T, Sahebkar A. Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions: state of the art. EXCLI J. 2023;22:53\u201366.","journal-title":"EXCLI J"},{"key":"2113_CR107","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/dom.14018","volume":"22","author":"S Mulder","year":"2020","unstructured":"Mulder S, Hammarstedt A, Nagaraj SB, Nair V, Ju W, Hedberg J, et al. A metabolomics-based molecular pathway analysis of how the sodium-glucose co-transporter-2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetes. Diabetes Obes Metab. 2020;22:1157\u201366.","journal-title":"Diabetes Obes Metab"},{"key":"2113_CR108","doi-asserted-by":"publisher","first-page":"116018","DOI":"10.1016\/j.jpba.2024.116018","volume":"242","author":"ME Alosaimi","year":"2024","unstructured":"Alosaimi ME, Alotaibi BS, Abduljabbar MH, Alnemari RM, Almalki AH, Serag A. Therapeutic implications of dapagliflozin on the metabolomics profile of diabetic rats: a GC-MS investigation coupled with multivariate analysis. J Pharm Biomed Anal. 2024;242:116018.","journal-title":"J Pharm Biomed Anal"},{"key":"2113_CR109","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1210\/clinem\/dgab078","volume":"106","author":"KM Love","year":"2021","unstructured":"Love KM, Liu Z. DPP4 activity, Hyperinsulinemia, and atherosclerosis. J Clin Endocrinol Metab. 2021;106:1553\u201365.","journal-title":"J Clin Endocrinol Metab"},{"key":"2113_CR110","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fendo.2019.00389","volume":"10","author":"B Gallwitz","year":"2019","unstructured":"Gallwitz B. Clinical use of DPP-4 inhibitors. Front Endocrinol (Lausanne). 2019;10:389.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2113_CR111","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/med.21513","volume":"39","author":"K Tomovic","year":"2019","unstructured":"Tomovic K, Lazarevic J, Kocic G, Deljanin-Ilic M, Anderluh M, Smelcerovic A. Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection. Med Res Rev. 2019;39:404\u201322.","journal-title":"Med Res Rev"},{"key":"2113_CR112","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s42003-021-01652-x","volume":"4","author":"YC Li","year":"2021","unstructured":"Li YC, Sung PH, Yang YH, Chiang JY, Yip HK, Yang CC. Dipeptidyl peptidase 4 promotes peritoneal fibrosis and its inhibitions prevent failure of peritoneal dialysis. Commun Biol. 2021;4:144.","journal-title":"Commun Biol"},{"key":"2113_CR113","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1165\/rcmb.2016-0186OC","volume":"58","author":"J Goodwin","year":"2018","unstructured":"Goodwin J, Choi H, Hsieh MH, Neugent ML, Ahn JM, Hayenga HN, et al. Targeting hypoxia-inducible Factor-1alpha\/Pyruvate dehydrogenase kinase 1 Axis by Dichloroacetate suppresses bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 2018;58:216\u201331.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2113_CR114","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.120.316443","volume":"126","author":"L Tian","year":"2020","unstructured":"Tian L, Wu D, Dasgupta A, Chen KH, Mewburn J, Potus F, et al. Epigenetic metabolic reprogramming of right ventricular fibroblasts in pulmonary arterial hypertension: a pyruvate dehydrogenase kinase-dependent shift in mitochondrial metabolism promotes right ventricular fibrosis. Circ Res. 2020;126:1723\u201345.","journal-title":"Circ Res"},{"key":"2113_CR115","doi-asserted-by":"publisher","first-page":"F1162","DOI":"10.1152\/ajprenal.00422.2018","volume":"316","author":"Q Wei","year":"2019","unstructured":"Wei Q, Su J, Dong G, Zhang M, Huo Y, Dong Z. Glycolysis inhibitors suppress renal interstitial fibrosis via divergent effects on fibroblasts and tubular cells. Am J Physiol Ren Physiol. 2019;316:F1162\u201372.","journal-title":"Am J Physiol Ren Physiol"},{"key":"2113_CR116","doi-asserted-by":"crossref","unstructured":"Virmani MA, Cirulli M. The role of l-Carnitine in Mitochondria, Prevention of metabolic inflexibility and disease initiation. Int J Mol Sci. 2022; 23.","DOI":"10.3390\/ijms23052717"},{"key":"2113_CR117","doi-asserted-by":"crossref","unstructured":"Pajak B, Siwiak E, Soltyka M, Priebe A, Zielinski R, Fokt I et al. 2-Deoxy-d-Glucose and its analogs: from Diagnostic to Therapeutic agents. Int J Mol Sci. 2019; 21.","DOI":"10.3390\/ijms21010234"},{"key":"2113_CR118","doi-asserted-by":"crossref","unstructured":"Jo SL, Yang H, Lee SR, Heo JH, Lee HW, Hong EJ. Curcumae Radix Decreases Neurodegenerative Markers through Glycolysis Decrease and TCA Cycle Activation. Nutrients. 2022; 14.","DOI":"10.3390\/nu14081587"},{"key":"2113_CR119","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","volume":"60","author":"KM Nelson","year":"2017","unstructured":"Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The essential Medicinal Chemistry of Curcumin. J Med Chem. 2017;60:1620\u201337.","journal-title":"J Med Chem"},{"key":"2113_CR120","doi-asserted-by":"crossref","unstructured":"Farzaei MH, Zobeiri M, Parvizi F, El-Senduny FF, Marmouzi I, Coy-Barrera E et al. Curcumin in Liver diseases: a systematic review of the Cellular mechanisms of oxidative stress and clinical perspective. Nutrients. 2018; 10.","DOI":"10.3390\/nu10070855"},{"key":"2113_CR121","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/labinvest.2015.59","volume":"95","author":"N Lian","year":"2015","unstructured":"Lian N, Jiang Y, Zhang F, Jin H, Lu C, Wu X, et al. Curcumin regulates cell fate and metabolism by inhibiting hedgehog signaling in hepatic stellate cells. Lab Invest. 2015;95:790\u2013803.","journal-title":"Lab Invest"},{"key":"2113_CR122","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s11658-019-0157-x","volume":"24","author":"JL Zhao","year":"2019","unstructured":"Zhao JL, Guo MZ, Zhu JJ, Zhang T, Min DY. Curcumin suppresses epithelial-to-mesenchymal transition of peritoneal mesothelial cells (HMrSV5) through regulation of transforming growth factor-activated kinase 1 (TAK1). Cell Mol Biol Lett. 2019;24:32.","journal-title":"Cell Mol Biol Lett"},{"key":"2113_CR123","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12906-019-2702-6","volume":"19","author":"JL Zhao","year":"2019","unstructured":"Zhao JL, Zhang T, Shao X, Zhu JJ, Guo MZ. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis. BMC Complement Altern Med. 2019;19:280.","journal-title":"BMC Complement Altern Med"},{"key":"2113_CR124","doi-asserted-by":"publisher","first-page":"e109628","DOI":"10.1371\/journal.pone.0109628","volume":"9","author":"TI Chang","year":"2014","unstructured":"Chang TI, Kang HY, Kim KS, Lee SH, Nam BY, Paeng J, et al. The effect of statin on epithelial-mesenchymal transition in peritoneal mesothelial cells. PLoS ONE. 2014;9:e109628.","journal-title":"PLoS ONE"},{"key":"2113_CR125","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.phrs.2014.03.002","volume":"88","author":"CR Sirtori","year":"2014","unstructured":"Sirtori CR. The pharmacology of statins. Pharmacol Res. 2014;88:3\u201311.","journal-title":"Pharmacol Res"},{"key":"2113_CR126","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1136\/gutjnl-2019-318237","volume":"69","author":"J Bosch","year":"2020","unstructured":"Bosch J, Gracia-Sancho J, Abraldes JG. Cirrhosis as new indication for statins. Gut. 2020;69:953\u201362.","journal-title":"Gut"},{"key":"2113_CR127","doi-asserted-by":"crossref","unstructured":"Kuo HF, Hsieh CC, Wang SC, Chang CY, Hung CH, Kuo PL et al. Simvastatin attenuates Cardiac Fibrosis via Regulation of Cardiomyocyte-Derived Exosome Secretion. J Clin Med. 2019; 8.","DOI":"10.3390\/jcm8060794"},{"key":"2113_CR128","doi-asserted-by":"publisher","first-page":"e18116","DOI":"10.1111\/jcmm.18116","volume":"28","author":"MA Elbaset","year":"2024","unstructured":"Elbaset MA, Mohamed B, Hessin A, Abd El-Rahman SS, Esatbeyoglu T, Afifi SM, et al. Nrf2\/HO-1, NF-kappaB and PI3K\/Akt signalling pathways decipher the therapeutic mechanism of pitavastatin in early phase liver fibrosis in rats. J Cell Mol Med. 2024;28:e18116.","journal-title":"J Cell Mol Med"},{"key":"2113_CR129","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3109\/0886022X.2010.508859","volume":"32","author":"Y Yenicerioglu","year":"2010","unstructured":"Yenicerioglu Y, Uzelce O, Akar H, Kolatan E, Yilmaz O, Yenisey C, et al. Effects of atorvastatin on development of peritoneal fibrosis in rats on peritoneal dialysis. Ren Fail. 2010;32:1095\u2013102.","journal-title":"Ren Fail"},{"key":"2113_CR130","doi-asserted-by":"publisher","first-page":"102168","DOI":"10.1016\/j.pupt.2022.102168","volume":"77","author":"D Andreikos","year":"2022","unstructured":"Andreikos D, Karampitsakos T, Tzouvelekis A, Stratakos G. Statins\u2019 still controversial role in pulmonary fibrosis: what does the evidence show? Pulm Pharmacol Ther. 2022;77:102168.","journal-title":"Pulm Pharmacol Ther"},{"key":"2113_CR131","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41467-023-35944-z","volume":"14","author":"TS Huang","year":"2023","unstructured":"Huang TS, Wu T, Wu YD, Li XH, Tan J, Shen CH, et al. Long-term statins administration exacerbates diabetic nephropathy via ectopic fat deposition in diabetic mice. Nat Commun. 2023;14:390.","journal-title":"Nat Commun"},{"key":"2113_CR132","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1590\/S0102-86502012000400012","volume":"27","author":"G Baroni","year":"2012","unstructured":"Baroni G, Schuinski AF, Berticelli PT, Silva MA, Gouveia DS, Pecoits Filho R, et al. The influence of simvastatin in induced peritoneal fibrosis in rats by peritoneal dialysis solution with glucosis 4.25%. Acta Cir Bras. 2012;27:350\u20136.","journal-title":"Acta Cir Bras"},{"key":"2113_CR133","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000339814","volume":"34","author":"T Xu","year":"2012","unstructured":"Xu T, Xie JY, Wang WM, Ren H, Chen N. Impact of rapamycin on peritoneal fibrosis and transport function. Blood Purif. 2012;34:48\u201357.","journal-title":"Blood Purif"},{"key":"2113_CR134","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1111\/febs.13740","volume":"283","author":"S Xiang","year":"2016","unstructured":"Xiang S, Li M, Xie X, Xie Z, Zhou Q, Tian Y, et al. Rapamycin inhibits epithelial-to-mesenchymal transition of peritoneal mesothelium cells through regulation of rho GTPases. FEBS J. 2016;283:2309\u201325.","journal-title":"FEBS J"},{"key":"2113_CR135","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1159\/000494144","volume":"48","author":"J Liu","year":"2018","unstructured":"Liu J, Zhu W, Jiang CM, Feng Y, Xia YY, Zhang QY, et al. Mammalian target of Rapamycin Complex 1 activation disrupts the low-density lipoprotein receptor pathway: a novel mechanism for Extracellular Matrix Accumulation in Human Peritoneal Mesothelial cells. Am J Nephrol. 2018;48:357\u201368.","journal-title":"Am J Nephrol"},{"key":"2113_CR136","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejphar.2015.11.004","volume":"785","author":"R Marion-Letellier","year":"2016","unstructured":"Marion-Letellier R, Savoye G, Ghosh S. Fatty acids, eicosanoids and PPAR gamma. Eur J Pharmacol. 2016;785:44\u20139.","journal-title":"Eur J Pharmacol"},{"key":"2113_CR137","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1101\/gad.349232.121","volume":"36","author":"W Hu","year":"2022","unstructured":"Hu W, Jiang C, Kim M, Xiao Y, Richter HJ, Guan D, et al. Isoform-specific functions of PPARgamma in gene regulation and metabolism. Genes Dev. 2022;36:300\u201312.","journal-title":"Genes Dev"},{"key":"2113_CR138","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3892\/mmr.2017.6196","volume":"15","author":"YF Zhang","year":"2017","unstructured":"Zhang YF, Wang Q, Su YY, Wang JL, Hua BJ, Yang S, et al. PPAR\u2013gamma agonist rosiglitazone protects rat peritoneal mesothelial cells against peritoneal dialysis solution\u2013induced damage. Mol Med Rep. 2017;15:1786\u201392.","journal-title":"Mol Med Rep"},{"key":"2113_CR139","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s10753-015-0193-2","volume":"38","author":"YF Zhang","year":"2015","unstructured":"Zhang YF, Zou XL, Wu J, Yu XQ, Yang X. Rosiglitazone, a peroxisome proliferator-activated receptor (PPAR)-gamma agonist, attenuates inflammation Via NF-kappaB inhibition in Lipopolysaccharide-Induced Peritonitis. Inflammation. 2015;38:2105\u201315.","journal-title":"Inflammation"},{"key":"2113_CR140","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ebiom.2018.10.072","volume":"38","author":"Z Lyu","year":"2018","unstructured":"Lyu Z, Mao Z, Li Q, Xia Y, Liu Y, He Q, et al. PPARgamma maintains the metabolic heterogeneity and homeostasis of renal tubules. EBioMedicine. 2018;38:178\u201390.","journal-title":"EBioMedicine"},{"key":"2113_CR141","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/1440-1681.12403","volume":"42","author":"X Su","year":"2015","unstructured":"Su X, Yu R, Yang X, Zhou G, Wang Y, Li L, et al. Telmisartan attenuates peritoneal fibrosis via peroxisome proliferator-activated receptor-gamma activation in rats. Clin Exp Pharmacol Physiol. 2015;42:671\u20139.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2113_CR142","doi-asserted-by":"publisher","first-page":"173076","DOI":"10.1016\/j.ejphar.2020.173076","volume":"880","author":"Q Wang","year":"2020","unstructured":"Wang Q, Xu L, Zhang X, Liu D, Wang R. GSK343, an inhibitor of EZH2, mitigates fibrosis and inflammation mediated by HIF-1alpha in human peritoneal mesothelial cells treated with high glucose. Eur J Pharmacol. 2020;880:173076.","journal-title":"Eur J Pharmacol"},{"key":"2113_CR143","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/path.5352","volume":"250","author":"Y Shi","year":"2020","unstructured":"Shi Y, Tao M, Wang Y, Zang X, Ma X, Qiu A, et al. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis. J Pathol. 2020;250:79\u201394.","journal-title":"J Pathol"},{"key":"2113_CR144","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/ndt\/gfz298","volume":"35","author":"H Kadoya","year":"2020","unstructured":"Kadoya H, Satoh M, Nishi Y, Kondo M, Wada Y, Sogawa Y, et al. Klotho is a novel therapeutic target in peritoneal fibrosis via wnt signaling inhibition. Nephrol Dial Transpl. 2020;35:773\u201381.","journal-title":"Nephrol Dial Transpl"},{"key":"2113_CR145","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/path.5987","volume":"258","author":"Y Shi","year":"2022","unstructured":"Shi Y, Li J, Chen H, Hu Y, Tang L, Wang Y, et al. Inhibition of EZH2 suppresses peritoneal angiogenesis by targeting a VEGFR2\/ERK1\/2\/HIF-1alpha-dependent signaling pathway. J Pathol. 2022;258:164\u201378.","journal-title":"J Pathol"},{"key":"2113_CR146","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jhep.2022.02.003","volume":"77","author":"MF Fondevila","year":"2022","unstructured":"Fondevila MF, Fernandez U, Heras V, Parracho T, Gonzalez-Rellan MJ, Novoa E, et al. Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis. J Hepatol. 2022;77:15\u201328.","journal-title":"J Hepatol"},{"key":"2113_CR147","doi-asserted-by":"crossref","unstructured":"Miguel V, Tituana J, Herrero JI, Herrero L, Serra D, Cuevas P et al. Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis. J Clin Invest. 2021; 131.","DOI":"10.1172\/JCI140695"},{"key":"2113_CR148","first-page":"63","volume":"10","author":"MY Jiang","year":"2023","unstructured":"Jiang MY, Man WR, Zhang XB, Zhang XH, Duan Y, Lin J, et al. Adipsin inhibits Irak2 mitochondrial translocation and improves fatty acid beta-oxidation to alleviate diabetic cardiomyopathy. Mil Med Res. 2023;10:63.","journal-title":"Mil Med Res"},{"key":"2113_CR149","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1750-1172-9-79","volume":"9","author":"V Aires","year":"2014","unstructured":"Aires V, Delmas D, Le Bachelier C, Latruffe N, Schlemmer D, Benoist JF, et al. Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts. Orphanet J Rare Dis. 2014;9:79.","journal-title":"Orphanet J Rare Dis"},{"key":"2113_CR150","doi-asserted-by":"publisher","first-page":"106363","DOI":"10.1016\/j.jsbmb.2023.106363","volume":"233","author":"Y Li","year":"2023","unstructured":"Li Y, Zhang Y, Deng Q, Mao J, Jia Z, Tang M, et al. Resveratrol reverses palmitic acid-induced cow neutrophils apoptosis through shifting glucose metabolism into lipid metabolism via Cav-1\/ CPT 1-mediated FAO enhancement. J Steroid Biochem Mol Biol. 2023;233:106363.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2113_CR151","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1080\/0886022X.2022.2126789","volume":"44","author":"J Wu","year":"2022","unstructured":"Wu J, Li J, Feng B, Bi Z, Zhu G, Zhang Y, et al. Activation of AMPK-PGC-1alpha pathway ameliorates peritoneal dialysis related peritoneal fibrosis in mice by enhancing mitochondrial biogenesis. Ren Fail. 2022;44:1545\u201357.","journal-title":"Ren Fail"},{"key":"2113_CR152","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1142\/S0192415X22500094","volume":"50","author":"ZH Li","year":"2022","unstructured":"Li ZH, Xu R, Shi J, Yu MS, Zhong Y, He WM, et al. Astragalus Total Saponins ameliorate peritoneal fibrosis by promoting mitochondrial synthesis and inhibiting apoptosis. Am J Chin Med. 2022;50:261\u201374.","journal-title":"Am J Chin Med"},{"key":"2113_CR153","doi-asserted-by":"publisher","first-page":"e0184332","DOI":"10.1371\/journal.pone.0184332","volume":"12","author":"K Hara","year":"2017","unstructured":"Hara K, Hamada C, Wakabayashi K, Kanda R, Kaneko K, Horikoshi S, et al. Scavenging of reactive oxygen species by astaxanthin inhibits epithelial-mesenchymal transition in high glucose-stimulated mesothelial cells. PLoS ONE. 2017;12:e0184332.","journal-title":"PLoS ONE"},{"key":"2113_CR154","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00795-021-00305-6","volume":"55","author":"H Inoue","year":"2022","unstructured":"Inoue H, Torigoe K, Torigoe M, Muta K, Obata Y, Suzuki T, et al. Mitochonic acid-5 ameliorates chlorhexidine gluconate-induced peritoneal fibrosis in mice. Med Mol Morphol. 2022;55:27\u201340.","journal-title":"Med Mol Morphol"},{"key":"2113_CR155","doi-asserted-by":"crossref","unstructured":"Selvarajah B, Azuelos I, Anastasiou D, Chambers RC. Fibrometabolism-An emerging therapeutic frontier in pulmonary fibrosis. Sci Signal. 2021; 14.","DOI":"10.1126\/scisignal.aay1027"},{"key":"2113_CR156","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1681\/ASN.2022040474","volume":"33","author":"K Bergling","year":"2022","unstructured":"Bergling K, Martus G, Oberg CM. Phloretin improves Ultrafiltration and reduces glucose absorption during peritoneal Dialysis in rats. J Am Soc Nephrol. 2022;33:1857\u201363.","journal-title":"J Am Soc Nephrol"},{"key":"2113_CR157","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s10157-014-0991-0","volume":"19","author":"L Zhang","year":"2015","unstructured":"Zhang L, Liu J, Liu Y, Xu Y, Zhao X, Qian J, et al. Fluvastatin inhibits the expression of fibronectin in human peritoneal mesothelial cells induced by high-glucose peritoneal dialysis solution via SGK1 pathway. Clin Exp Nephrol. 2015;19:336\u201342.","journal-title":"Clin Exp Nephrol"},{"key":"2113_CR158","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/labinvest.2010.111","volume":"90","author":"P Sandoval","year":"2010","unstructured":"Sandoval P, Loureiro J, Gonzalez-Mateo G, Perez-Lozano ML, Maldonado-Rodriguez A, Sanchez-Tomero JA, et al. PPAR-gamma agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage. Lab Invest. 2010;90:1517\u201332.","journal-title":"Lab Invest"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02113-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02113-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02113-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T20:04:23Z","timestamp":1747857863000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02113-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":158,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2113"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02113-2","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Funding section has been updated.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}